Literature DB >> 11121654

Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI).

F Wenz1, S Steinvorth, F Lohr, S Fruehauf, S Wildermuth, M van Kampen, M Wannenmacher.   

Abstract

PURPOSE: Prospective evaluation of chronic radiation effects on the healthy adult brain using neuropsychological testing of intelligence, attention, and memory. METHODS AND MATERIALS: 58 patients (43 +/- 10 yr) undergoing hyperfractionated total body irradiation (TBI) (TBI, 14.4 Gy, 12 x 1.2 Gy in 4 days) before bone marrow or peripheral blood stem cell transplantation were prospectively included. Twenty-one recurrence-free long-term survivors were re-examined 6-36 months (median 27 months) after completion of TBI. Neuropsychological testing included assessment of general intelligence, attention, and memory using normative, standardized psychometric tests. Mood status was controlled, as well. Test results are given as IQ scores (population mean 100) or percentiles for attention and memory (population mean 50).
RESULTS: The 21 patients showed normal baseline test results of IQ (101 +/- 13) and attention (53 +/- 28), with memory test scores below average (35 +/- 21). Test results of IQ (98 +/- 17), attention (58 +/- 27), and memory (43 +/- 28) showed no signs of clinically measurable radiation damage to higher CNS (central nervous system) functions during the follow-up. The mood status was improved.
CONCLUSION: The investigation of CNS toxicity after hyperfractionated TBI showed no deterioration of test results in adult recurrence-free patients with tumor-free CNS. The median follow-up of 27 months will be extended.

Entities:  

Mesh:

Year:  2000        PMID: 11121654     DOI: 10.1016/s0360-3016(00)00764-1

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  8 in total

Review 1.  [White matter alterations after chemotherapy and radiation].

Authors:  A Simgen
Journal:  Radiologe       Date:  2018-12       Impact factor: 0.635

2.  Prospective neurocognitive function over 5 years after allogeneic hematopoietic cell transplantation for cancer survivors compared with matched controls at 5 years.

Authors:  Karen L Syrjala; Samantha B Artherholt; Brenda F Kurland; Shelby L Langer; Sari Roth-Roemer; JoAnn Broeckel Elrod; Sureyya Dikmen
Journal:  J Clin Oncol       Date:  2011-05-02       Impact factor: 44.544

Review 3.  Potential toxicities of prophylactic cranial irradiation.

Authors:  Frank A Giordano; Grit Welzel; Yasser Abo-Madyan; Frederik Wenz
Journal:  Transl Lung Cancer Res       Date:  2012-12

4.  A prospective evaluation of changes in brain structure and cognitive functions in adult stem cell transplant recipients.

Authors:  D D Correa; J C Root; R Baser; D Moore; K K Peck; E Lis; T B Shore; H T Thaler; A Jakubowski; N Relkin
Journal:  Brain Imaging Behav       Date:  2013-12       Impact factor: 3.978

5.  Prospective assessment of white matter integrity in adult stem cell transplant recipients.

Authors:  D D Correa; Y Wang; J D West; K K Peck; J C Root; R E Baser; H T Thaler; T B Shore; A Jakubowski; A J Saykin; N Relkin
Journal:  Brain Imaging Behav       Date:  2016-06       Impact factor: 3.978

6.  Acute neurocognitive impairment during cranial radiation therapy in patients with intracranial tumors.

Authors:  Grit Welzel; Katharina Fleckenstein; Sabine K Mai; Brigitte Hermann; Uta Kraus-Tiefenbacher; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2008-12-24       Impact factor: 3.621

Review 7.  [Normal tissue: radiosensitivity, toxicity, consequences for planning].

Authors:  A Rühle; P E Huber
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

Review 8.  A systematic review and meta-analysis of changes in cognitive functioning in adults undergoing hematopoietic cell transplantation.

Authors:  K M Phillips; H L McGinty; J Cessna; Y Asvat; B Gonzalez; M G Cases; B J Small; P B Jacobsen; J Pidala; H S L Jim
Journal:  Bone Marrow Transplant       Date:  2013-05-06       Impact factor: 5.483

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.